Delivery Order SPE2DR25D2100-SPE2DR26FA0SU
- Not listed
- The Defense Logistics Agency awarded a $9.44K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Prevymis 480 mg tablets (7-count units), with completion targeted for October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,973.46 by the Defense Logistics Agency on December 17, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled at the vendor's location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for $4,973.46 to supply Prevymis 480 mg tablets (7-count packages) with a firm fixed price. The award, issued on November 28, 2025, is scheduled for completion by December 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on December 17, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by January 9, 2026, with performance originating from the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating AmerisourceBergen competed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for PREVYMIS 480 MG tablets (7-count packaging) valued at $4,719.34. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,973.46 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Prevymis 480 mg tablets (seven-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by December 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical distributor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $4,745.80 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (14-count) on August 26, 2025, with completion scheduled for September 17, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) with a ceiling value of $4,973.46 and a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, is scheduled for ultimate completion on December 16, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $17,710.96 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0SUDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $9,946.92 by the Defense Logistics Agency (DLA) for the supply of Prevymis (cytomegalovirus prophylaxis) 480 mg tablets in a seven-tablet package. This firm fixed-price delivery order, issued on December 18, 2025, is scheduled for completion by January 12, 2026, with performance to be executed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation applied. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp provides a comprehensive portfolio of medications and medical supplies to support military healthcare systems worldwide through the DLA's global pharmaceutical support framework. The company's continued engagement through delivery orders such as this demonstrates its critical role as a preferred vendor for federal military and veteran healthcare pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/17/25 |